Crestwood Advisors Group LLC Cuts Position in iShares Biotechnology ETF (NASDAQ:IBB)

Crestwood Advisors Group LLC reduced its position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 4.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 23,527 shares of the financial services provider’s stock after selling 1,040 shares during the […]

Related Keywords

,Goldman Sachs Group Inc ,Nasdaq ,Wells Fargo Company ,Citigroup Inc ,Moneta Group Investment Advisors ,Securities Exchange Commission ,Nasdaq Biotechnology Index Fund ,Crestwood Advisors Group ,Shares Biotechnology ,Free Report ,Advisors Group ,Group Investment Advisors ,Sachs Group ,Street Group ,Wells Fargo ,Shares Nasdaq Biotechnology ,Shares Nasdaq Biotechnology Index Fund ,Industry Classification Benchmark ,Ishares Biotechnology Etf ,Nasdaq Ibb ,Ibb ,Finance ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,